蛋白

Recombinant Human Bcl-w (minus C-Terminus) Protein, CF

824-BW-050

50微克

458美元

824-BW

824-BW-050

Recombinant Human Bcl-w (minus C-Terminus) Protein, CF

The Recombinant Human Bcl-w (minus C-Terminus) Protein, CF from R&D Systems is derived from E. coli. The Recombinant Human Bcl-w (minus C-Terminus) Protein, CF has been validated for the following applications: Inhibition Activity.

Bcl-w

蛋白和酶

50微克

Supplied as a 0.2 µm filtered solution in HEPES, NaCl and Glycerol.

未共轭

>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.

人类

18 kDa, under reducing and non-reducing conditions

19.5 kDa

BCL2L2

Measured by its ability to inhibit Caspase-8-cleaved BID-mediated release of cytochrome c from isolated mouse liver mitochondria using the Rat/Mouse Cytochrome c Quantikine ELISA (Catalog # MCTC0 ) to quantify cytochrome c. The typical EC50 is between 50 and 250 nM in the presence of 54 nM Recombinant Human BID Caspase-8-cleaved (Catalog # 882-B8 ). Optimal dilutions should be determined by each laboratory for each application.

<0.01 EU per 1 µg of the protein by the LAL method.

Q92843

抑制作用活性

E. coli-derived Recombinant Human Bcl-w (minus C-Terminus) Protein

458美元

Apoptosis regulator Bcl-W, Bcl2-L-2, BCL2L2, BCL2-like 2, Bclw, BCL-W, BCLWbcl-2-like protein 2, KIAA0271BCL2-L-2

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70 °C as supplied. 3 months, -20 to -70 °C under sterile conditions after opening.